Haleon Belgium
La probabilité de faillite calculée de Haleon Belgium sur 12 mois est de 0,3% (très faible). L'entreprise est active depuis 1968 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 58 ans |
| Direction | 4 |
| Sites | 1 |
| Publications | 25 |
Estimation statistique fondée sur des sources publiques, pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2024 | volledig | 21-08-2025 | 2025-00447507 |
| 31-12-2023 | volledig | 03-10-2024 | 2024-00504113 |
| 31-12-2022 | volledig | 04-07-2023 | 2023-00226763 |
| 31-12-2021 | volledig | 30-05-2022 | 2022-20050556 |
| 31-12-2020 | volledig | 15-06-2021 | 2021-20700151 |
| 31-12-2019 | volledig | 13-07-2020 | 2020-29500518 |
| 31-12-2018 | volledig | 04-09-2019 | 2019-63900101 |
| 31-12-2017 | volledig | 10-09-2018 | 2018-62600354 |
| 31-12-2016 | volledig | 30-11-2017 | 2017-70800462 |
| 31-12-2015 | volledig | 27-07-2016 | 2016-37800480 |
-
Marco DorigoAdministrateurActe Moniteur 24003060 (05-01-2024)Actif05-01-2024 → auj.
-
Sabena SolomonAdministrateur déléguéActe Moniteur 22061047 (19-05-2022)Actif19-05-2022 → auj.
-
Gilles MartinAdministrateurActe Moniteur 24003060 (05-01-2024)Actif01-10-2020 → auj.
3 événements
- 05-01-2024 Nommé· Administrateur
- 19-05-2022 Nommé· Administrateur
- 01-10-2020 Nommé· Administrateur
-
Jorg Van DammeAdministrateurActe Moniteur 24003060 (05-01-2024)Actif26-02-2019 → auj.
3 événements
- 05-01-2024 Nommé· Administrateur
- 19-05-2022 Nommé· Administrateur
- 26-02-2019 Nommé· Administrateur
Historique, non confirmé récemment (3)
-
Sofi NAERTAdministrateurActe Moniteur 16111564 (08-08-2016)Non confirmé récemmentdernière confirmation dans un acte de 2016
-
Anne DelzongleAdministrateurActe Moniteur 07081013 (07-06-2007)Non confirmé récemmentdernière confirmation dans un acte de 2007
-
Andrew WatersAdministrateurActe Moniteur 05110644 (01-08-2005)Non confirmé récemmentdernière confirmation dans un acte de 2005
Representants permanents (1)
-
Ellemarie BexVaste vertegenwoordiger commissarisActe Moniteur 23164895 (22-12-2023)Representant permanent22-12-2023 → auj.
Anciens dirigeants (15)
-
Dries PattynAdministrateur déléguéActe Moniteur 20114643 (01-10-2020)Ancien01-10-2020 → 06-06-2023
3 événements
- 06-06-2023 Démission· Gedelegeerd bestuurder en bestuurder
- 19-05-2022 Démission· Administrateur délégué
- 01-10-2020 Nommé· Administrateur délégué
-
Hans MoonsAdministrateurActe Moniteur 19011556 (23-01-2019)Ancien23-01-2019 → 01-10-2020
2 événements
- 01-10-2020 Démission· Administrateur
- 23-01-2019 Nommé· Administrateur
-
James BarhamAdministrateurActe Moniteur 18186083 (31-12-2018)Ancien31-12-2018 → 01-10-2020
3 événements
- 01-10-2020 Démission· Administrateur délégué
- 31-12-2018 Nommé· Administrateur
- 31-12-2018 Nommé· Administrateur délégué
-
Libor BALLEKAdministrateurActe Moniteur 16111564 (08-08-2016)Ancien25-07-2016 → 26-02-2019
3 événements
- 26-02-2019 Démission· Administrateur
- 08-08-2016 Nommé· Administrateur
- 25-07-2016 Nommé· Administrateur
-
Celesta BloemenAdministrateurActe Moniteur 17160702 (16-11-2017)Ancien16-11-2017 → 23-01-2019
2 événements
- 23-01-2019 Démission· Administrateur
- 16-11-2017 Nommé· Administrateur
| Commissaire / réviseur | Numéro IRE/IBR | Période |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLActif Commissaire |
- | 22-12-2023 → auj. |
Afficher 8 commissaires précédents
| Deloitte Bedrijfsrevisoren BV Commissaire |
- | - → 22-12-2023 |
| Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL Commissaire remplacé par KPMG Bedrijfsrevisoren BV/SRL en 2023 |
- | 16-11-2021 → 22-12-2023 |
| Deloitte Réviseurs d'Entreprises SCRL Commissaire remplacé par Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL en 2021 |
- | 29-01-2019 → 16-11-2021 |
| Didier DELANOYE Commissaire remplacé par Deloitte Réviseurs d'Entreprises SCRL en 2019 |
- | 08-08-2016 → 29-01-2019 |
| Emmanuelle Attout Commissaire remplacé par SCCRL PwC Reviseurs d'Entreprises en 2016 |
- | 04-08-2010 → 08-08-2016 |
| PricewaterhouseCoopers Reviseurs d'Entreprises SCRL Commissaire remplacé par Emmanuelle Attout en 2010 |
- | 07-06-2007 → 04-08-2010 |
| PricewaterhouseCoopers Réviseurs d'Entreprises SCRL Commissaire |
- | - → 29-01-2019 |
| SCCRL PwC Reviseurs d'Entreprises Commissaire remplacé par Deloitte Réviseurs d'Entreprises SCRL en 2019 |
- | 08-08-2016 → 29-01-2019 |
| NACE primaire | Commerce de gros de produits pharmaceutiques et médicaux(46460) |
| Forme juridique | SA(014) |
| Date de constitution | 01-01-1968 |
| Status | Actif |
| Code postal | 1930 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 23094D0081/00F003 | Flandre | 8 103 m² | 1 · 1 497 m² | 38,6 m · 12 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
Nous connaissons 33 actes du Moniteur belge pour cette entreprise. Aucun n'a encore été lu : ce qui s'y trouve n'a ici été ni constaté ni réfuté.
05-01-2024 3 administrateurs nommés
- Marco Dorigo, Bestuurder
- Gilles Martin, Bestuurder
- Jorg Van Damme, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marco Dorigo",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}22-12-2023 2 administrateurs nommés, 1 démissionnaire
- KPMG Bedrijfsrevisoren BV/SRL, Commissaris
- Ellemarie Bex, Vaste vertegenwoordiger commissaris
- Deloitte Bedrijfsrevisoren BV, Commissaris
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "KPMG Bedrijfsrevisoren BV/SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Ellemarie Bex",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}06-06-2023 Dries Pattyn démissionne de son mandat de gedelegeerd bestuurder en bestuurder
- Dries Pattyn, Gedelegeerd bestuurder en bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd bestuurder en bestuurder",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}02-03-2023 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": null,
"notary": {
"name": "Tim Carnewal",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-03-02",
"filing_date": null,
"act_kind_objet": "TRANSFERT DU SIEGE VERS LA REGION FLAMANDE"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-02-17",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "demerged",
"address": "1300 Wavre, Avenue Pascal 2-4-6",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Le si\u00E8ge social de la soci\u00E9t\u00E9 est transf\u00E9r\u00E9 de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. L\u0027activit\u00E9 de la soci\u00E9t\u00E9 est maintenue, mais la langue de fonction passera au n\u00E9erlandais.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim Carnewal",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare a d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge social de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. \u00C0 compter de ce transfert, la langue de la soci\u00E9t\u00E9 deviendra le n\u00E9erlandais.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "zetel"
}24-02-2023 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}24-02-2023 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}19-05-2022 3 administrateurs nommés, 1 démissionnaire
- Gilles Martin, Bestuurder
- Sabena Solomon, Gedelegeerd bestuurder
- Jorg Van Damme, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Sabena Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}16-11-2021 Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL nommé commissaire
- Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL, Commissaire
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Glaxosmithkline Consumer Healthcare"
}
}01-10-2020 2 administrateurs nommés, 2 démissionnaires
- Gilles Martin, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
- Hans Moons, Bestuurder
- James Barham, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}26-02-2019 1 administrateur nommé, 1 démissionnaire
- Jorg Van Damme, Bestuurder
- Libor Ballek, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor Ballek",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}29-01-2019 1 administrateur nommé, 1 démissionnaire
- Deloitte Réviseurs d'Entreprises SCRL, Commissaire
- PricewaterhouseCoopers Réviseurs d'Entreprises SCRL, Commissaire
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}23-01-2019 1 administrateur nommé, 1 démissionnaire
- Hans Moons, Bestuurder
- Celesta Bloemen, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}31-12-2018 2 administrateurs nommés, 1 démissionnaire
- James Barham, Bestuurder
- James Barham, Gedelegeerd bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}13-04-2018 2 administrateurs nommés, 2 démissionnaires
- Olivier Bronkhorst, Bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
- Bas Vorsteveld, Bestuurder
- Bas Vorsteveld, Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}16-11-2017 1 administrateur nommé, 1 démissionnaire
- Celesta Bloemen, Bestuurder
- Sofie Naert, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofie Naert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}12-06-2017 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}17-10-2016 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": "completed",
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-10-17",
"filing_date": "2016-07-11",
"act_kind_objet": "FUSION PAR ABSORPTION DE NOVARTIS CONSUMER HEALTH -"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-09-26",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "acquiring",
"address": "Site Apollo, avenue Pascal 2-4-6, 1300 Wavre",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "NOVARTIS CONSUMER HEALTH",
"role": "absorbed",
"address": "1800 Vilvoorde, Medialaan 40",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103",
"693"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 nouvelles actions au nom de la Soci\u00E9t\u00E9 Absorbante contre remise de 1 action de la Soci\u00E9t\u00E9 Absorb\u00E9e",
"new_shares_issued_n": 208637,
"real_estate_included": false,
"patrimony_description": "La totalit\u00E9 du patrimoine de la Soci\u00E9t\u00E9 Absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9e \u00E0 titre universel \u00E0 la Soci\u00E9t\u00E9 Absorbante. L\u0027op\u00E9ration inclut le transfert universel du patrimoine, y compris les actifs, passifs et droits.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Eubelius",
"person_name": null,
"org_rep_person_name": "Rebecca Danby, Ewout Epping, Jorg van Damme"
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare, r\u00E9unie le 26 septembre 2016, a approuv\u00E9 la fusion par absorption de NOVARTIS CONSUMER HEALTH, dont le patrimoine a \u00E9t\u00E9 transf\u00E9r\u00E9 universellement \u00E0 la soci\u00E9t\u00E9 absorbante. Cette fusion a \u00E9t\u00E9 effectu\u00E9e conform\u00E9ment aux dispositions de l\u0027article 693 du Code des soci\u00E9t\u00E9s, avec attribution de 208.637 nouvelles actions \u00E0 l\u0027actionnaire unique de la soci\u00E9t\u00E9 absorb\u00E9e, au taux d\u0027\u00E9change de 695,46 nouvelles actions par action existante. Le capital social de GlaxoSmithKline Consumer Healthcare a \u00E9t\u00E9 augment\u00E9 \u00E0 5.798.470,50 EUR.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une procuration",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}08-08-2016 4 administrateurs nommés, 2 démissionnaires
- Libor BALLEK, Bestuurder
- Sofi NAERT, Bestuurder
- SCCRL PwC Reviseurs d'Entreprises, Commissaire
- Didier DELANOYE, Commissaire
- Simon HODGE, Bestuurder
- Carlton LAWSON, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor BALLEK",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofi NAERT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SCCRL PwC Reviseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}25-07-2016 Publication au Moniteur belge, Divers
Détails techniques
{
"stage": "proposal",
"notary": {
"name": "Joris De Wolf",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-07-25",
"filing_date": "2016-06-23",
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-06-23",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare SA",
"role": "acquiring",
"address": "Avenue Pascal 2-4-6, 1300 Wavre (Belgique)",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "Novartis Consumer Health NV",
"role": "absorbed",
"address": "Medialaan 40, 1800 Vilvoorde (Belgique)",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"693",
"74",
"648"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 Nouvelles Actions pour chaque action",
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Tous les actifs et passifs de Novartis Consumer Health NV sont transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA par un transfert d\u0027universalit\u00E9. Le patrimoine transf\u00E9r\u00E9 inclut les activit\u00E9s pharmaceutiques, chimiques et alimentaires, ainsi que les brevets, marques et licences associ\u00E9s.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Joris De Wolf",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption pr\u00E9voit la dissolution sans liquidation de Novartis Consumer Health NV, dont tous les actifs et passifs seront transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA. En \u00E9change, les actionnaires de NVS Belgique recevront 695,46 nouvelles actions nominatives sans valeur nominale. La fusion prendra effet le 1er octobre 2016, avec une r\u00E9troactivit\u00E9 comptable et fiscale \u00E0 partir du 1er janvier 2016. Les assembl\u00E9es g\u00E9n\u00E9rales extraordinairement des actionnaires seront tenues vers le 23 septembre 2016.",
"co_filed_documents": [
"Rapport du commissaire de NVS Belgique",
"Rapport du commissaire de GSK Belgique",
"Comptes annuels des trois derniers exercices de GSK Belgique et NVS Belgique",
"Rapports du conseil d\u0027administration et du commissaire pour les trois derniers exercices"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}04-02-2016 Bas Vorsteveld nommé administrateur
- Bas Vorsteveld, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}17-06-2015 3 administrateurs nommés, 3 démissionnaires
- Carlton LAWSON, Bestuurder
- Simon HODGE, Bestuurder
- Bas VORSTEVELD, Bestuurder
- Anton VAN DE PUTTE, Bestuurder
- Adrian BAUER, Bestuurder
- René FLASCHKER, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anton VAN DE PUTTE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Adrian BAUER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ren\u00E9 FLASCHKER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas VORSTEVELD",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}04-08-2010 Emmanuelle Attout nommé commissaire
- Emmanuelle Attout, Commissaire
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Emmanuelle Attout",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}09-02-2009 Act object · Incorporation · General meeting · Board meeting
- Act object: constitution et nomination des premiers administrateurs et de l'administrateur-délégué · Belgian Association of Consumer Healthcare Industry
- Publication: 2009-02-09 · Belgian Association of Consumer Healthcare Industry
- Filing: 2009-01-29 · Belgian Association of Consumer Healthcare Industry
- Incorporation: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- General meeting: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- Board meeting: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- Purpose: la représentation et la défense des intérêts moraux et matériels de l'industrie Consumer Healthcare étant, au sens large du terme, l'ensemble des entreprises actives en Belgique dans le domaine des médicaments qui peuvent être délivrés sans ordonnance comme des produits qui ne tombent pas sous l'appellation de médicaments. · Belgian Association of Consumer Healthcare Industry
- First fiscal year: 2008-12-12 to 2009-12-31 · Belgian Association of Consumer Healthcare Industry
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Hernando Acosta-Stoefs
- Officer appointment: role: administrateur, start_date: 2008-12-12 · An De Mulder
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Marc Gryseels
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Guido Van Hoeck
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Marc Verlinden
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Hans De Seranno
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Gerrit Coremans
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Luc Huys
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Laurent Bendavid
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Tim Southerst
- Officer appointment: role: administrateur-délégué, start_date: 2008-12-12 · Marc Gryseels
- Officer appointment: role: président, start_date: 2008-12-12 · Marc Verlinden
- Officer appointment: role: vice-président, start_date: 2008-12-12 · Guido Van Hoeck
- Officer appointment: role: trésorier, start_date: 2008-12-12 · Gerrit Coremans
- Mandate term: au moins jusqu'à l'Assemblée Générale qui doit approuver les comptes annuels se rapportant à l'exercice comptable 2011, après quoi le système de rotation de l'article 11 entre en vigueur · Belgian Association of Consumer Healthcare Industry
Détails techniques
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: constitution et nomination des premiers administrateurs et de l\u0027administrateur-d\u00E9l\u00E9gu\u00E9",
"value": "constitution et nomination des premiers administrateurs et de l\u0027administrateur-d\u00E9l\u00E9gu\u00E9",
"object": null,
"subject": "e1"
},
{
"date": "2009-02-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/02/2009 - Annexes du Moniteur belge",
"value": "2009-02-09",
"object": null,
"subject": "e1"
},
{
"date": "2009-01-29",
"type": "filing",
"quote": "29-01-2009",
"value": "2009-01-29",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "incorporation",
"quote": "Le 12 d\u00E9cembre 2008, les soussign\u00E9s, fondateurs de l\u0027Association, ... ont d\u00E9cid\u00E9 de constituer une association sans but lucratif de droit belge",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "general_meeting",
"quote": "Apr\u00E8s avoir \u00E9tabli les statuts de l\u0027Association, les fondateurs ont tenu une Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale et ont adopt\u00E9 les r\u00E9solutions suivantes \u00E0 l\u0027unanimit\u00E9:",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "board_meeting",
"quote": "Apr\u00E8s l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale, un Conseil d\u0027Administration s\u0027est \u00E9galement tenu en date du 12/12/2008.",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"type": "purpose",
"quote": "L\u0027Association a pour objet social la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie Consumer Healthcare \u00E9tant, au sens large du terme, l\u0027ensemble des entreprises actives en Belgique dans le domaine des m\u00E9dicaments qui peuvent \u00EAtre d\u00E9livr\u00E9s sans ordonnance comme des produits qui ne tombent pas sous l\u0027appellation de m\u00E9dicaments.",
"value": "la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie Consumer Healthcare \u00E9tant, au sens large du terme, l\u0027ensemble des entreprises actives en Belgique dans le domaine des m\u00E9dicaments qui peuvent \u00EAtre d\u00E9livr\u00E9s sans ordonnance comme des produits qui ne tombent pas sous l\u0027appellation de m\u00E9dicaments.",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "first_fiscal_year",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale a d\u00E9cid\u00E9 que le premier exercice social d\u00E9butera ce jour et s\u0027ach\u00E8vera le 31 d\u00E9cembre 2009.",
"value": "2008-12-12 to 2009-12-31",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "L\u0027 Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale a d\u00E9cid\u00E9 de nommer comme administrateurs les personnes suivantes: *Monsieur Hernando Acosta-Stoefs, General Manager, domicili\u00E9 \u00E0 1790 Affligem, Zwarteberg 59, ayant comme num\u00E9ro de registre national 66.01.24-333.49:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e11"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Madame An De Mulder, Business Unit Director, domicili\u00E9e \u00E0 9660 Brakel, Boekelstraat 17, ayant comme num\u00E9ro de registre nalional 66.05.20-406.27;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e12"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Marc Gryseels, domicili\u00E9 \u00E0 Lasne, 1380, Rue Collart, 3A, ayant comme num\u00E9ro de registre national 61.10.24-037.12;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e13"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Guido Van Hoeck, Country Manager, domicili\u00E9 \u00E0 Kapelle-op-den-Bos, 1880, Overzetstraat 28. ayant comme num\u00E9ro de registre national 55.05.18-157.08:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e14"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Marc Verlinden, administrateur-d\u00E9l\u00E9gu\u00E9, domicili\u00E9 \u00E0 Beersel, 1653, Beukenlaan, 60, ayant comme num\u00E9ro de registre national 69.09.03-391.61;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e15"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Hans De Seranno, Sales Manager Pharmacy Benelux, domicili\u00E9 \u00E0 Destelbergen 9070, Gaverstraat 31, ayant comme num\u00E9ro de registre national 63.04.01-033.27:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e16"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Gemit Coremans, OTC Director, domicili\u00E9 \u00E0 Lennik 1750, Waterhoflaan 45, ayant comme num\u00E9ro de registre national 57.05.29-395.64;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e17"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Luc Huys, General Manager, repr\u00E9sent\u00E9 par Monsieur Leo Vervoort, domicili\u00E9 \u00E0 Kapelien 2950. Blauwhof Hoevensebaan 206/2, ayant comme num\u00E9ro de registre national 60.05.06-013.35;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e18"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Laurent Bendavid, Marketing Manager, domicili\u00E9 \u00E0 _ ayant comme num\u00E9ro de registre national 67.02.18-133.69;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e19"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Tim Southerst, Director, domicili\u00E9 \u00E0_ ayant comme num\u00E9ro de registre national GBR passport n\u00B0705059517;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e20"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "1.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de l\u0027Association: -Monsieur Marc Gryseels, pr\u00E9cil\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e13"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "2.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 de pr\u00E9sident de l\u0027Association: -Monsieur Marc Verlinden, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "pr\u00E9sident",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e15"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "3.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 de vice-pr\u00E9sident de l\u0027Association: -Monsieur Guido Van Hoeck, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "vice-pr\u00E9sident",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e14"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "4. d\u00E9sign\u00E9 la personne suivante en quasit\u00E9 de tr\u00E9sorier de l\u0027Association: -Monsieur Gerrit Coremans, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "tr\u00E9sorier",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e17"
},
{
"type": "mandate_term",
"quote": "En guise de mesure provisoire, les premiers membres du Conseil d\u0027Administration qui sont nomm\u00E9s actuellement rempliront leur mandat au moins jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale qui doit approuver les comptes annuels se rapportant \u00E0 l\u0027exercice comptable 2011. A partir de ce moment, le syst\u00E8me de rotation, tel que mis en place \u00E0 l\u0027article 11 des pr\u00E9sents statuts, entrera en vigueur.",
"value": "au moins jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale qui doit approuver les comptes annuels se rapportant \u00E0 l\u0027exercice comptable 2011, apr\u00E8s quoi le syst\u00E8me de rotation de l\u0027article 11 entre en vigueur",
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"kbo \u002709.465.691\u0027 invalid -\u003E register 0809.465.691"
],
"model_id": 53,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 34932,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0809.465.691",
"kind": "company",
"name": "Belgian Association of Consumer Healthcare Industry",
"attrs": {
"seat": "Rue Collart 3A, 1380 Lasne",
"kbo_raw": "09.465.691",
"kbo_source": "register",
"legal_form": "ASBL",
"short_name": "BACHI"
}
},
{
"id": "e2",
"kbo": "0400.948.213",
"kind": "company",
"name": "BAYER",
"attrs": {
"seat": "1050 Bruxelles, avenue Louise 143",
"legal_form": "SA"
}
},
{
"id": "e3",
"kbo": "0404.195.238",
"kind": "company",
"name": "GLAXOSMITHKLINE CONSUMER HEALTHCARE",
"attrs": {
"seat": "1332 Genval, rue du Tilleul 13",
"legal_form": "SA"
}
},
{
"id": "e4",
"kbo": "0452.453.827",
"kind": "company",
"name": "MCNEIL",
"attrs": {
"seat": "2600 Berchem, Roderveldlaan 1",
"legal_form": "SCA"
}
},
{
"id": "e5",
"kbo": "0401.988.388",
"kind": "company",
"name": "MELISANA",
"attrs": {
"seat": "1140 Evere, Kareelovenlaan 1",
"legal_form": "SA"
}
},
{
"id": "e6",
"kbo": "0462.252.213",
"kind": "company",
"name": "NEOCARE",
"attrs": {
"seat": "1020 Bruxelles, Esplanade du Heysel 22",
"legal_form": "SA"
}
},
{
"id": "e7",
"kbo": "0403.097.356",
"kind": "company",
"name": "NOVARTIS CONSUMER HEALTH",
"attrs": {
"seat": "1800 Vilvoorde, Medialaan 30, bte 5",
"legal_form": "SA"
}
},
{
"id": "e8",
"kbo": "0414.882.559",
"kind": "company",
"name": "NYCOMED",
"attrs": {
"seat": "1080 Bruxelles, Chauss\u00E9e de Gand 615",
"legal_form": "SA"
}
},
{
"id": "e9",
"kbo": "0403.086.468",
"kind": "company",
"name": "QUALIPHAR",
"attrs": {
"seat": "2880 Bornem, Rijksweg 9",
"legal_form": "SA"
}
},
{
"id": "e10",
"kbo": "0860.530.550",
"kind": "company",
"name": "METHAPHARMA",
"attrs": {
"seat": "8400 Oostende, Wetenschapspark 1",
"legal_form": "SA"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Hernando Acosta-Stoefs",
"attrs": {
"rrn": "66.01.24-333.49",
"address": "1790 Affligem, Zwarteberg 59"
}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "An De Mulder",
"attrs": {
"rrn": "66.05.20-406.27",
"address": "9660 Brakel, Boekelstraat 17"
}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Marc Gryseels",
"attrs": {
"rrn": "61.10.24-037.12",
"address": "Lasne, 1380, Rue Collart, 3A"
}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Guido Van Hoeck",
"attrs": {
"rrn": "55.05.18-157.08",
"address": "Kapelle-op-den-Bos, 1880, Overzetstraat 28"
}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Marc Verlinden",
"attrs": {
"rrn": "69.09.03-391.61",
"address": "Beersel, 1653, Beukenlaan, 60"
}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Hans De Seranno",
"attrs": {
"rrn": "63.04.01-033.27",
"address": "Destelbergen 9070, Gaverstraat 31"
}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Gerrit Coremans",
"attrs": {
"rrn": "57.05.29-395.64",
"address": "Lennik 1750, Waterhoflaan 45"
}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Luc Huys",
"attrs": {
"rrn": "60.05.06-013.35",
"address": "Kapelien 2950, Blauwhof Hoevensebaan 206/2"
}
},
{
"id": "e19",
"kbo": null,
"kind": "person",
"name": "Laurent Bendavid",
"attrs": {
"rrn": "67.02.18-133.69",
"address": null
}
},
{
"id": "e20",
"kbo": null,
"kind": "person",
"name": "Tim Southerst",
"attrs": {
"rrn": "GBR passport n\u00B0705059517",
"address": null
}
}
]
}07-06-2007 2 administrateurs nommés, 1 démissionnaire
- Anne Delzongle, Bestuurder
- PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
- Georges Dassonville, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Georges Dassonville",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anne Delzongle",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}01-08-2005 1 administrateur nommé, 1 démissionnaire
- Andrew Waters, Bestuurder
- Schipper, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Schipper",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Andrew Waters",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}| Dénomination légaleFR | Haleon Belgium |
| Dénomination légaleNL | Haleon Belgium |